Single Pass is a developer of a disposable bipolar electrocautery device.
Single Pass has raised $460K in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Single Pass's investors include TCA Venture Group, Grant Van Cleve, Kyto Technology and Life Science Inc.
Single Pass is headquartered in Lake Forest, United States.
Single Pass is a developer of a disposable bipolar electrocautery device.
Single Pass is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Single Pass — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/single-pass. Accessed September 30, 2026.
VCBacked. (2022). Single Pass — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/single-pass
{{cite web |title=Single Pass — Funding & Investors |url=https://www.vcbacked.co/company/single-pass |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated